International Myeloma Foundation
IMF Tip Card: Abecma (idecabtagene vicleucel, “ide-cel”)
IMF Tip Card: Abecma (idecabtagene vicleucel, “ide-cel”)
Couldn't load pickup availability
Abecma® (idecabtagene vicleucel, “ide-cel”) is the first-in-class B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell immunotherapy approved by the U.S. Food and Drug Administration (FDA) for use in myeloma. Abecma is a personalized immune cell therapy delivered as a one-time infusion, manufactured for each individual patient using the patient’s own white blood cells (T cells).
You can also download a copy of this tip card at: https://www.myeloma.org/resource-library/tip-card-abecma.
-
Shipping Information
FREE SHIPPING for all tip cards and publications.
Shipping times typically take 7-14 business days. Orders totaling up to $49.99 will incur a shipping cost of $5; orders totaling $50 and up will incur a shipping cost of $10.
Currently, the IMF does not provide international shipping via our Shopify store. If you are planning to purchase IMF merchandise or to order free educational publications outside of the U.S. (including U.S. territories), please contact the IMF directly at the imf@myeloma.org or 1-818-487-7455.